1 research outputs found
TNF-related apoptosis-inducing ligand, interferon gamma-induced protein 10, and C-reactive protein in predicting the progression of SARS-CoV-2 infection : a prospective cohort study
Background: Early prognostication of COVID-19 severity will potentially improve patient care. Biomarkers,
such as TNF-related apoptosis-inducing ligand (TRAIL), interferon gamma-induced protein 10 (IP-10), and
C-reactive protein (CRP), might represent possible tools for point-of-care testing and severity prediction.
Methods: In this prospective cohort study, we analyzed serum levels of TRAIL, IP-10, and CRP in patients
with COVID-19, compared them with control subjects, and investigated the association with disease sever ity.
Results: A total of 899 measurements were performed in 132 patients (mean age 64 years, 40.2% females).
Among patients with COVID-19, TRAIL levels were lower (49.5 vs 87 pg/ml, P = 0.0142), whereas IP-10
and CRP showed higher levels (667.5 vs 127 pg/ml, P <0.001; 75.3 vs 1.6 mg/l, P <0.001) than healthy
controls. TRAIL yielded an inverse correlation with length of hospital and intensive care unit (ICU) stay,
Simplified Acute Physiology Score II, and National Early Warning Score, and IP-10 showed a positive cor relation with disease severity. Multivariable regression revealed that obesity (adjusted odds ratio [aOR]
5.434, 95% confidence interval [CI] 1.005-29.38), CRP (aOR 1.014, 95% CI 1.002-1.027), and peak IP-10 (aOR
1.001, 95% CI 1.00-1.002) were independent predictors of in-ICU mortality